Pharmacogenetic Testing: Does it Improve Therapy in Patients With MDD?
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Diagnosis & Disease Information
23andMe Develops Drug Compound Using Consumer Genetic Data
23andMe, a consumer genetics company, has licensed its first drug compound to Almirall, a global pharmaceutical company.
New Trial Attempts to Make Genetic Counseling and Testing More Accessible
The researchers wrote that “genetic counseling must be further explored to find an optimal balance of clinical quality with increased access and financial sustainability.”
Tracing the Effect of the MC4R Pathway in Obesity (TEMPO): A Breakthrough Registry for Underdiagnosed Rare Genetic Disorders
Results of an epidemiologic analysis indicated that approximately 12,800 individuals in the United States may have biallelic mutations in key proteins along the MC4R pathway.
Clinicians Should Address Concerns and Limitations of DTC Genetic Testing
Risks related to DTC testing include lack of understanding of the test by the consumer, incorrect test results, and erroneous interpretation of the results.
Genetic Testing Recommended for All Patients With Breast Cancer
Researchers from the American Society of Breast Surgeons outlined recommendations for genetic testing that medical professionals can use for assessing hereditary risk for breast cancer.
Which Epilepsy Panel Is Most Cost-Effective for Genetic Testing?
A strategy using initial evaluation with whole-exome sequencing or epilepsy panel, and then, if these are negative, chromosomal microarray, is supported for patients with epilepsy of unknown etiology, according to study results.
Limited Psychological Harms Associated With Genetic Testing for Disease
Genetic testing for cancer, cardiovascular, and neurodegenerative diseases presents a low psychological burden in patients and should be considered.
Direct-to-Consumer Genetic Test for MUTYH-Associated Polyposis Cleared
While more than 100 variants in the MUTYH gene have been linked with MUTYH-associated polyposis, the MUTYH-Associated Polyposis Genetic Health Risk report identifies the 2 most common genetic variants in people of Northern European ancestry.
Alzheimer Disease Biomarkers Expose Individuals to Long-Term Care Insurance Denial
Approximately 5.5 million Americans have Alzheimer disease or dementia.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...